Márcia Waddington-Cruz

16PUBLICATIONS
111CO-AUTHORS
Gene and molecular therapyPeripheral nervous systemNutritional epidemiologyTissue engineeringPanel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 15, 2026
Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial.

|Sep 04, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.

|Jul 09, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.

|Jun 15, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

|May 09, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.

|Apr 06, 2026
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.

Márcia Waddington Cruz, John L Berk, Yeşim Parman

Pageof 3

Frequent Collaborators

5 joint publications

Laura Obici

4 joint publications

Mathew S Maurer

3 joint publications

Marcus Vinicius Pinto

3 joint publications

Moises Dias da Silva